NCT06622798View on ClinicalTrials.gov

Exploratory Study on the Correlation Between HRD Score and PARPi Efficacy Based on Chinese Ovarian Cancer Patients

RecruitingOBSERVATIONAL

Enrollment

470

Participants

Timeline

Start Date

August 20, 2024

Primary Completion Date

January 1, 2025

Study Completion Date

July 7, 2026

Conditions

Exploring the Correlation of HRD Score Pairs with the Prognosis of Chinese Ovarian Cancer Patients and the Outcome of Maintenance Therapy with PARPi

Interventions

OTHER

Non-interventional

Non-interventional

Trial Locations (1)

510060

RECRUITING

Sun Yat-sen memorial hospital, Guangzhou

Sponsors

Collaborators (1)

Amoy Diagnostics

All Listed Sponsors

collaborator

Amoy Diagnostics

INDUSTRY

lead

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

OTHER